KRT5 and breast cancer: Here, we present evidence that myoepithelial lineage restricted K5−/K19− myoepithelial progenitor cells (MPCs) derived from bipotent K5+/K19− stem/progenitor cells share a molecular gene expression signature with claudin-low breast cancer subtype.